In addition, Western blotting assay also indicated that SMI-4a enhanced the protein levels of Atg5, LC3-II and Beclin1 in a dose-dependent manner in melanoma cells (Fig. 3b), indicating that SMI-4a could induce autophagy in melanoma cells. The gene discussed is ATG5; the disease is melanoma.